These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31332440)

  • 21. New Therapies to Correct the Cystic Fibrosis Basic Defect.
    Bergeron C; Cantin AM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.
    Ensinck MM; Carlon MS
    Cells; 2022 Jun; 11(12):. PubMed ID: 35740997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy in cystic fibrosis.
    Prickett M; Jain M
    Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The porcine lung as a potential model for cystic fibrosis.
    Rogers CS; Abraham WM; Brogden KA; Engelhardt JF; Fisher JT; McCray PB; McLennan G; Meyerholz DK; Namati E; Ostedgaard LS; Prather RS; Sabater JR; Stoltz DA; Zabner J; Welsh MJ
    Am J Physiol Lung Cell Mol Physiol; 2008 Aug; 295(2):L240-63. PubMed ID: 18487356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant Adeno-Associated Virus-Mediated Editing of the G551D Cystic Fibrosis Transmembrane Conductance Regulator Mutation in Ferret Airway Basal Cells.
    Yan Z; Vorhies K; Feng Z; Park SY; Choi SH; Zhang Y; Winter M; Sun X; Engelhardt JF
    Hum Gene Ther; 2022 Oct; 33(19-20):1023-1036. PubMed ID: 35686451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
    Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
    PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancing clinical development pathways for new CFTR modulators in cystic fibrosis.
    Mayer-Hamblett N; Boyle M; VanDevanter D
    Thorax; 2016 May; 71(5):454-61. PubMed ID: 26903594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome Editing for Cystic Fibrosis.
    Wang G
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Will Airway Gene Therapy for Cystic Fibrosis Improve Lung Function? New Imaging Technologies Can Help Us Find Out.
    Parsons D; Donnelley M
    Hum Gene Ther; 2020 Sep; 31(17-18):973-984. PubMed ID: 32718206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the Root Cause of Cystic Fibrosis.
    Trescott L; Holcomb J; Spellmon N; Mcleod C; Aljehane L; Sun F; Li C; Yang Z
    Curr Drug Targets; 2015; 16(9):933-44. PubMed ID: 25316272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modifier gene studies to identify new therapeutic targets in cystic fibrosis.
    Dorfman R
    Curr Pharm Des; 2012; 18(5):674-82. PubMed ID: 22229572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for cystic fibrosis: an example for lung gene therapy.
    Griesenbach U; Geddes DM; Alton EW
    Gene Ther; 2004 Oct; 11 Suppl 1(Suppl 1):S43-50. PubMed ID: 15454956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Molecular Genetics and the long road to treating cystic fibrosis.
    Harris A
    Hum Mol Genet; 2021 Oct; 30(R2):R264-R273. PubMed ID: 34245257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee TW; Southern KW; Perry LA; Penny-Dimri JC; Aslam AA
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005599. PubMed ID: 27314455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning.
    Barry PJ; Ronan N; Plant BJ
    Semin Respir Crit Care Med; 2015 Apr; 36(2):287-98. PubMed ID: 25826594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystic fibrosis: a look into the future of prenatal screening and therapy.
    Nishida K; Smith Z; Rana D; Palmer J; Gallicano GI
    Birth Defects Res C Embryo Today; 2015 Mar; 105(1):73-80. PubMed ID: 25820246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.
    Fanen P; Wohlhuter-Haddad A; Hinzpeter A
    Int J Biochem Cell Biol; 2014 Jul; 52():94-102. PubMed ID: 24631642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on new and emerging therapies for cystic fibrosis.
    Hudock KM; Clancy JP
    Expert Opin Emerg Drugs; 2017 Dec; 22(4):331-346. PubMed ID: 29264936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.